Ohio’s Vote Could Add New State to Booming U.S. Cannabis Marketplace

As Neutra Corp. (NTRR) and its joint venture partner, Surface to Air Solutions (S2O2), continue working to add to their growing list of horticultural clients, the booming U.S. cannabis market appears poised to grow even larger this November. Voters in Ohio will decide whether to legalize cannabis for medical and adult use on... more →
Posted in: Press

In Five Years Time, Oregon Cannabis Industry Will Be Worth $500M, Experts Say

GTSO is also catering to the rapidly growing business-to-business sector of the states cannabis economy by working to establish a trusted and reliable cannabis testing lab to help ensure that retailers and their patients can be sure of exactly what they are purchasing. As the nationwide market for cannabis continues to grow, GTSO... more →
Posted in: Stocks

This Is Not The Medical Marijuana Stock That You Want

I like the risk-reward situation here, at a market cap under $700 million, than I did when the company was over $1.2 billion, but only for an investor that’s willing to hold for multiple years. In this biotech market, it’s hard to say whether GW Pharmaceuticals has hit bottom, especially since it’s trading considerably... more →
Posted in: Investing, News, Stocks

GW Pharmaceuticals Announces Appointment of Julian Gangolli to Board of Directors

GW Pharmaceuticals plc (Nasdaq:GWPH) (AIM:GWP) (“GW,” “the Company” or “the Group”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, announced that the Company has appointed Julian Gangolli... more →
Posted in: Press

Marijuana Stocks To Watch Out For, According To NASDAQ

Thanks to Sativex, it has a solid revenue stream, generating over $46 million in the last 12 months. The company’s cash position also looks pretty good, with $234 million in cash and cash equivalents. 2. Insys Therapeutics Insys Therapeutics’ financial position looks even better than GW Pharmaceuticals, but not from any... more →
Posted in: Investing

Booming Cannabis Industry’s Need For Quality Control Can Be Solved

Last year’s landmark Gallup poll indicated that for the first time since Gallup started polling in 1969 (only 12% favored legalizing it back then) more than half of Americans (58%) are in favor of marijuana being legalized, and we continue to see indicators that the trend towards legalization is proceeding at a rapid pace throughout... more →
Posted in: Press

NASDAQ’s Recommendation: 3 Marijuana Stocks To Watch

Insys also sells generic Dronabinol SG, a second-line cannabinoid drug used for chemotherapy-induced nausea and vomiting and anorexia associated with weight loss in patients with AIDS. Dronabinol SG isn’t making a big financial impact for Insys, but the company does have two other marijuana-based drugs in development that could... more →
Posted in: Investing

3 Marijuana Stocks To Watch, According to NASDAQ

Unfortunately, some could be headed for such a disaster with marijuana stocks. With several states fully legalizing cannabis and others allowing medicinal use of the drug, money has poured into companies that seem poised to profit from the nascent market. The problem is that investors could very well see their dollars go up in smoke... more →
Posted in: Investing
1 2 3 4 5